Mr Mrs Miss Ms Dr Other

Dr
Alex
Bruce

Trainee Patent Attorney

London Office York Office

Life sciences

Telephone. +44(0) 190 473 2120
Email. abruce@hgf.com
Vcard
Linkedin

Experience

Alex joined HGF in August 2022 as a Trainee Patent Attorney within the Life Sciences group.

He has a broad technical background in the Biosciences with a BSc (Hons) in Biochemistry and Microbiology, MSc in Medical Microbiology, and a PhD in Molecular and Cellular Biology. During his MSc at the University of Manchester, he carried out research on novel drugs to treat Tuberculosis, and was awarded the WWC Topley Prize for obtaining the highest overall marks in his written examinations.

Following this, he carried out doctoral research at the University of Leeds investigating the mechanical mechanisms of Staphylococcus aureus biofilm formation on the molecular scale.

In 2023, Alex obtained his Postgraduate Certificate in Intellectual Property from Bournemouth University.

Alex has a keen interest in Biochemistry, Biotechnology, Molecular Biology, and Microbiology.

Specialisms

Industries

Services

Qualifications

Trainee

BSC

BSc (Hons) in Biochemistry and Microbiology

MSC

MSc in Medical Microbiology

PHD

PhD in Molecular and Cellular Biology

POSTGRADUATE DIPLOMA OR CERTIFICATE

PG Cert Intellectual Property

Recognition

WWC Topley Prize (2017)

This prize is awarded each year to the MSc Medical Microbiology student with the highest overall marks (above distinction level) at the University of Manchester

Publications

A leading case - beware sequence errors in patent claims

View publication online

Exam Success at HGF!

View publication online

Collagen-like Motifs of SasG: A Novel Fold for Protein Mechanical Strength

View publication online

Conferences: 2022

11-10-2022

HGF CPD Conference 2022

Attended

Related News

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Read article

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article

IAM Global Leaders 2026

HGF is proud to announce that we have 3 partners listed as an IAM Global Leader 2026. To qualify for inclusion in the IAM Global Leaders, individuals must be ranked …

Read article

The Bite of Implied Consent: Lessons from the Pink Lady Case

A recent European Union court decision considers the issue of implied consent to commercialise a plant variety, and whether the evidence meets the threshold of “serious doubts” of the validity …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us